Live Cell Imaging Market Scenario
Increasing incidence of cancer, technological advancements in the field of Live Cell Imaging and rising acceptance of high-content screening techniques in drug discovery are some of the major factors propelling the Live Cell Imaging market globally. Furthermore, rising government funding is also one of the factor propelling the growth of live cell imaging market. However, high cost of high-content screening systems is one of the major factor expected to hamper the global growth of the market.
Live Cell Imaging Market Segmentation
The Live Cell Imaging market is segmented by Product & Service, Technology, Application, End User and Geography. The Product & Service studied in the report are Instruments (Cell Analyzers, Microscopes, Standalone Systems and Accessories), Consumables (Reagents, Assay Kits, Media and Other Consumables), Software and Services. Furthermore, the Technology comprises of Fluorescence Recovery after Photobleaching (FRAP), Fluorescence Resonance Energy Transfer (FRET), High-Content Screening (HCS), Time-Lapse Microscopy and Other Technologies. Moreover, the Application include Cell Biology, Stem Cells, Developmental Biology and Drug Discovery Control. In addition, Live Cell Imaging products are used in various End User such as Pharmaceutical & Biotechnology Companies, Academic & Research Institutes and Contract Research Organizations. Additionally, the Global Live Cell Imaging Market is studied for the key regions such as, North America, Europe, Asia Pacific and Rest of the World.
Live Cell Imaging Market by Geography
Based on geography, the live cell imaging market is studied across the countries of key regions such as, North America, Europe, Asia Pacific and RoW. Among all the regions, the North America is anticipated to hold the major share of the global Live Cell Imaging market. The US dominates the North American live cell imaging market primarily due to the strong trend of pharmaceutical & biotechnology research and the high burden of cancer.
Live Cell Imaging Market Key Players
Some of the major players operating in the global Live Cell Imaging market includes Becton, Dickinson And Company, Biotek Instruments, INC., Bruker Corporation, Carl Zeiss AG, Cytosmart Technologies, Danaher Corporation, Etaluma, INC., GE Healthcare, Merck KGAA, Nanoentek INC., Nikon Corporation, Olympus Corporation, Perkinelmer INC., Sartorius AG and Thermo Fisher Scientific. Many companies in this market implement initiatives such as mergers and acquisitions, product developments, and geographic penetration to compete in the market.
Live Cell Imaging Market Report Key Benefits